Released : January 22, 2018 07:00 RNS Number : 4641C MaxCyte, Inc. 22 January 2018 MaxCyte, Inc. ("MaxCyte" or the "Company") Trading Update Gaithersburg, Maryland - 22 January 2018: MaxCyte (LSE: MXCT, MXCR), a US-based global company driving the acceleration of the discovery,
Released : January 12, 2018 17:13 RNS Number : 7976B MaxCyte, Inc. 12 January 2018 MaxCyte, Inc. ("MaxCyte" or the "Company") Total Voting Rights Maryland, USA - 12 January 2018: MaxCyte (LSE: MXCT, MXCR) announces that, following an exercise of options, 18,293 new shares of common
Released : November 30, 2017 15:26 RNS Number : 0291Y MaxCyte, Inc. 30 November 2017 MaxCyte, Inc. ("MaxCyte" or the "Company") Total Voting Rights Maryland, USA - 30 November 2017: MaxCyte (LSE: MXCT, MXCR) announces that, following an exercise of options, 41,121 new shares of common
Released : September 19, 2017 07:00 RNS Number : 0903R MaxCyte, Inc. 19 September 2017 MaxCyte, Inc. ("MaxCyte" or the "Company") Results for the Six Months ended 30 June 2017 Maryland, USA - 19 September 2017 - MaxCyte (LSE: MXCT, MXCR), a US-based global company driving the
Released : July 20, 2017 18:02 RNS Number : 6906L MaxCyte, Inc. 20 July 2017 MaxCyte, Inc. ("MaxCyte" or the "Company") Grant of Options Maryland, USA - 20 July 2017: MaxCyte (LSE: MXCT, MXCR), a US-based global company dedicated to driving the acceleration of the discovery,
Released : July 12, 2017 07:00 RNS Number : 7813K MaxCyte, Inc. 12 July 2017 MaxCyte, Inc. ("MaxCyte" or the "Company") Trading Update Maryland, USA - 12 July 2017: MaxCyte (LSE: MXCT, MXCR), a US-based global company dedicated to driving the acceleration of the discovery, development,
Released : May 31, 2017 16:30 RNS Number : 7231G MaxCyte, Inc. 31 May 2017 MaxCyte, Inc. ("MaxCyte" or the "Company") Total Voting Rights Maryland, USA -31 May 2017: MaxCyte (LSE: MXCT, MXCR) announces that, following an exercise of options, 22,435 new shares of common stock of $0.01
Released : May 02, 2017 13:42 RNS Number : 9212D MaxCyte, Inc. 02 May 2017 MaxCyte, Inc. ("MaxCyte" or the "Company") Block Listing Application MaxCyte (AIM: MXCT, MXCR) provides notification that an application has been made to the London Stock Exchange for admission to AIM for a block
Released : April 20, 2017 18:00 RNS Number : 9189C MaxCyte, Inc. 20 April 2017 THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, TO US PERSONS (AS DEFINED IN REGULATION S UNDER
Released : April 13, 2017 13:00 RNS Number : 4800C MaxCyte, Inc. 13 April 2017 MaxCyte, Inc. ("MaxCyte" or the "Company") Notice of AGM and 2016 Annual Report and Accounts Maryland, USA - 13 April 2017: MaxCyte (LSE: MXCT), a US-based global company dedicated to driving the acceleration
